Search

Reset

Searching with a thematic focus on Health systems, Access to medicines

Showing 1-10 of 170 results

Pages

  • Document

    Exploring pathways for building trust in vaccination and strengthening health system resilience

    BioMed Central, 2016
    Trust is critical to generate and maintain demand for vaccines in low and middle income countries. However, there is little documentation on how health system insufficiencies affect trust in vaccination and the process of re-building trust once it has been compromised.
  • Document

    Out of the reach of children? Young people’s health-seeking agency in Africa’s newly-emerging therapeutic landscapes

    University of Durham, 2011
    The dominant view within Western biomedicine is that children are vulnerable and in need of adult protection, while medicines are powerful, dangerous and should be controlled by experts, however, a growing literature suggests that children and adolescents (in both Western and developing-country contexts) often take active roles in health-seeking.
  • Document

    Intrapartum oxytocin (mis)use in South Asia

    Journal of Health Studies, 2009
    Oxytocin is a natural hormone with uterine stimulant properties that plays a prominent role in obstetric practice. Clinical guidelines for oxytocin use intrapartum emphasise that injudicious use has serious potential for adverse outcomes for mother and baby. Oxytocin is readily available in South Asia and widely used in ways that flout these guidelines.
  • Document

    Children’s mobility in Ghana: An overview of methods and findings from the Ghana research study

    Society, Biology and Human Affairs, 2011
    This paper is part of a collection forming A Special Issue, which covers selected themes from a larger project on child mobility in Ghana, Malawi and South Africa. The themes are those which individual members of the Ghana research team identified as of particular interest and on which they have reflected, drawing on material collected and analysed by the team as a whole.
  • Document

    Factsheet: Diabetes in older people

    HelpAge International, 2016
    There are two main types of diabetes. Type 2 accounts for over 90 per cent of diabetes worldwide. It results from the body’s ineffective use of insulin, leading to raised glucose levels in the blood. One of the four leading global NCDs2, diabetes is a major cause of chronic illness and morbidity:
  • Document

    Despite gains, barriers keep health care high on Africa’s priority list

    Afrobarometer, 2016
    Access to health care gained the spotlight on national and international development agendas when the 1978 Alma Ata Declaration outlined a strategy for achieving universal access to primary health care by the year 2000 (World Health Organization, 1978).
  • Document

    India Africa partnership in health care: accomplishments and prospects

    Research and Information System for Developing Countries, 2015
    The health sector assumes special importance in India-Africa development cooperation. It is the major component of the broad-ranging collaborative effort envisaged under the rubric of India-Africa cooperation in social development and capacity building.
  • Document

    Assessment of the COMPACK Program

    Philippine Institute for Development Studies, 2016
    This study is an assessment of the Complete Treatment Pack (COMPACK) Program that aims to ensure that the poorest of the poor are assured access to medicines for common diseases in the country. The main objective of the program is to realize decreased health-care cost. One positive effect of the program is the shortening of delivery time of medicines.
  • Document

    How effective has the Generics Act Been?

    Philippine Institute for Development Studies, 2016
    The Philippine government passed the Generics Act of 1988 to ensure that inexpensive and effective drugs are made available to all Filipinos. The law aims to supply and promote low-priced quality medicines as alternatives to the widely consumed but more expensive originator brands by requiring physicians to include in their prescriptions both the generic and brand names of the medicines.

Pages